Recent

% | $
Quotes you view appear here for quick access.

Intercept Pharmaceuticals, Inc. Message Board

  • abachann abachann Jan 18, 2014 3:03 PM Flag

    Let me explain; the drug reverses liver scars, ballooning, and removes liver fat which would otherwise

    lead to definite liver failure. The drug should be in the market yesterday. Liver transplants cost 1 million dollars and they can sell the NASH treatment for 100,000 dollars to 6 million patients that are stage 3, 4
    NASH which if left untreated causes cirrhosis or liver failure. I bought some stock in my IRA for the long term at 365.
    This is big; that's why the trial was stopped. I would like to buy more but I dont want to concentrate my whole portfolio in one stock. I have seen this happen before with Acorda. Look at their chart for comparison. That went from 2 to 40 and now trades around 30. The FDA should approve this now and save lives and treatment cost. The FDA is slow and some of their employees have been known to take bribes. That's why the FDA is unpredictable.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ICPT
158.20+5.04(+3.29%)Jul 22 4:00 PMEDT